Related Experiment Video
Updated: Jul 5, 2025

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Leptin deficiency, a potential mechanism for impaired fetal lung development in uteroplacental insufficiency?
Srirupa Hari Gopal1, Roopali Donepudi2, Mohan Pammi3
1Dept. of Pediatrics, Division of Neonatology, Baylor College of Medicine & Texas Children's Hospital, Houston, TX, USA.
Insights
Uteroplacental insufficiency (UPI) in rats led to decreased leptin and impaired lung development. Leptin may be crucial for fetal lung growth and respiratory outcomes in growth restriction.
Area of Science:
- Reproductive biology and developmental origins of health and disease.
Background:
- Uteroplacental insufficiency (UPI) is a primary cause of fetal growth restriction (FGR).
- Leptin, an adipokine, is vital for fetal organogenesis and has been found deficient in growth-restricted fetuses.
Purpose of the Study:
- To investigate the relationship between leptin expression and lung development in a rat model of UPI-induced FGR.
- To explore associations between lung development, serum leptin, and metabolic markers in FGR.
Main Methods:
- Induction of UPI in pregnant rats to create an FGR model.
- Analysis of lung leptin expression, lung morphometry (surface area, volume, radial alveolar count), serum leptin, von Willebrand factor, and metabolomic profiles.
Main Results:
- UPI-induced FGR rats exhibited significantly decreased lung leptin expression.
- Impaired lung development was observed in FGR rats, characterized by reduced lung surface area and volume.
- A significant association was found between lung radial alveolar count, serum leptin, von Willebrand factor, and specific metabolites.
Conclusions:
- Leptin deficiency and impaired lung development are present in UPI-induced FGR rats.
- Leptin plays a role in fetal lung growth and development, suggesting potential therapeutic value for respiratory outcomes in FGR.
- Further human studies are needed to confirm these findings.
Abstract:
Uteroplacental insufficiency (UPI) is a major cause of fetal growth restriction (FGR). Leptin, an adipokine, has been shown to play a vital role in fetal organogenesis. There is evidence reporting leptin deficiency in preterm and growth-restricted fetuses. In this issue of Pediatric Research, Yuliana et al. report leptin expression and lung development in UPI-induced FGR rats. UPI-induced FGR rats expressed decreased lung leptin and had impaired lung development, as shown by decreased surface area and lung volume. They also found a significant association between lung radial alveolar count, serum leptin, von Willebrand factor, and specific metabolites on metabolomic analyses. Previous studies on leptin supplementation in vivo have been associated with improvement in lung maturation; supporting the evidence, that leptin improves lung growth and development in FGR and may have future therapeutic potential in the improvement of respiratory outcomes in these infants. Future studies to support evidence of this association in humans are warranted.
More Related Videos
12:17The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
Published on: August 2, 2017
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Related Concept Videos
Inborn Errors of Metabolism
Teratogenicity
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...